Browse medicines, page 8 of 10
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Showing 421–480 of 546 records
Teplizumab-Mzwv (Tzield)
Protein medicineApproved in the United States (FDA)Expanded recordTildrakizumab-Asmn (Ilumya)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Kfce (Yesintek)
Protein medicineApproved in the United States (FDA)Expanded recordVaricella-Zoster Virus Strain Oka/Merck Live Antigen (Varivax)
Protein medicineLaboratory or animal-stage researchExpanded recordVelmanase Alfa-Tycv (Lamzede)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Non-central nervous system manifestations of alpha-mannosidosis
Eculizumab-Aeeb (Bkemv)
Protein medicineApproved in the United States (FDA)Expanded recordMumps Virus Strain B Level Jeryl Lynn Live Antigen (M-M-R II / Proquad)
Protein medicineLaboratory or animal-stage researchExpanded recordNeisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen (Menquadfi)
Protein medicineLaboratory or animal-stage researchExpanded recordNemolizumab-Ilto (Nemluvio)
Protein medicineApproved in the United States (FDA)Expanded recordOvine Digoxin Immune Fab (Digifab)
Protein medicineLaboratory or animal-stage researchExpanded recordPalifermin (Kepivance)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of autologous hematopoietic stem cell support. Kepivance is indicated as supportive care for preparative regimens predicted to result in ≥ WHO Grade 3 mucositis in the majority of patients.
Pectinase
Protein medicineDietary supplement; not FDA-approved as a medicineExpanded recordPegademase Bovine (Adagen)
Protein medicineApproved in the United States (FDA)Expanded recordPegfilgrastim-Apgf (Nyvepria)
Protein medicineApproved in the United States (FDA)Expanded recordPegfilgrastim-Fpgk (Stimufend)
Protein medicineApproved in the United States (FDA)Expanded recordPegfilgrastim-Unne (Armlupeg)
Protein medicineApproved in the United States (FDA)Expanded recordPegloticase (Krystexxa)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Chronic gout
Pegunigalsidase alfa (Elfabrio)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Confirmed Fabry disease
Pegunigalsidase Alfa-Iwxj (Elfabrio)
Protein medicineApproved in the United States (FDA)Expanded recordPegzilarginase (Loargys)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Hyperargininemia
Pivekimab Sunirine-Pvzy (Decnupaz)
Protein medicineApproved in the United States (FDA)Expanded recordPlasma Protein Fraction (Octaplas)
Protein medicineLaboratory or animal-stage researchExpanded recordPolatuzumab Vedotin (Polivy)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Relapsed or refractory DLBCL, NOS, after at least two prior therapies
Polatuzumab Vedotin-Piiq (Polivy)
Protein medicineApproved in the United States (FDA)Expanded recordPoractant alfa (Curosurf)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
The rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants
Pozelimab-Bbfg (Veopoz)
Protein medicineApproved in the United States (FDA)Expanded recordRasburicase (Elitek)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
The initial management of plasma uric acid levels
Ravulizumab-Cwvz (Ultomiris)
Protein medicineApproved in the United States (FDA)Expanded recordRelatlimab-Rmbw (Opdualag)
Protein medicineApproved in the United States (FDA)Expanded recordReteplase (Retavase)
Protein medicineApproved in the United States (FDA)Expanded recordRomosozumab-Aqqg (Evenity)
Protein medicineApproved in the United States (FDA)Expanded recordRozanolixizumab-Noli (Rystiggo)
Protein medicineApproved in the United States (FDA)Expanded recordSacituzumab Govitecan-Hziy (Trodelvy)
Protein medicineApproved in the United States (FDA)Expanded recordSalmonella Typhi Ty2 VI Polysaccharide Antigen (Typhim VI)
Protein medicineLaboratory or animal-stage researchExpanded recordSargramostim (Leukine)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
LEUKINE is a leukocyte growth factor indicated: To shorten time to neutrophil recovery and to reduce the incidence of severe and life-threatening infections and infections resulting in death following induction chemotherapy in adult patients 55 years and older with acute myeloid leukemia (AML). ( 1.1 ) For the mobilization of hematopoietic progenitor cells into peripheral blood for collection by leukapheresis and autologous transplantation in adult patients.
Sibeprenlimab-Szsi (Voyxact)
Protein medicineApproved in the United States (FDA)Expanded recordSomatropin [rdna Origin] (Nutropin)
Protein medicineApproved in the United States (FDA)Expanded recordStreptococcus Pneumoniae Type 10a Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 14 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 14 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 17f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 18c Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 19f Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 20 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 23f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 23f Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 33f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 3 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 5 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 6a Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Capvaxive / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 6b Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 6b Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 7f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 9n Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 9v Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordTagraxofusp (Elzonris)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Blastic plasmacytoid dendritic cell neoplasm
Tarlatamab-Dlle (Imdelltra)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy
Tebentafusp (Kimmtrak)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
HLA-A*02
Tebentafusp-Tebn (Kimmtrak)
Protein medicineApproved in the United States (FDA)Expanded recordTeclistamab-Cqyv (Tecvayli)
Protein medicineApproved in the United States (FDA)Expanded record